IgG/IgM COVID Rapid Test
The Rapid IgM-IgG Combined Antibody Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.
On March 16, 2020 the FDA updated its Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency. The updates include guidance for commercial manufacturers such as DentMed Supply for serology test that identify antibodies (e.g., IgM, IgG) to sARS-CoV-2 from clinical specimens. The policy allows testing in laboratories or by healthcare workers at the point-of-care. The policy does not apply to at-home testing.
Laboratories and healthcare providers must include this information in their patient test report as specified in FDA guidance:
- This test has not been reviewed by FDA
- Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
- Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
- Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
This product has CE-IVD registration.
Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protection against the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,
indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV. The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which means that the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended diagnostic methods.
Returns and exchanges are not accepted on most items due to the nature of our products. Please contact us if you have any questions.
We stand behind our products 100%. If you are unhappy with your purchase please let us know so that we can make it right.
- We ship Monday - Saturday via USPS
- Priority Delivery via the Postal Service normally will take 2-4 business days
- Shipping and handling charges include order processing, packaging, shipping and handling
If you have any questions, please contact us via email at email@example.com